Join the Prevnar 20 group to help and get support from people like you.
Prevnar 20 News
Providers Have Inadequate Awareness of PCV20 Vaccination Recommendations
FRIDAY, Sept. 8, 2023 – Two-thirds of health care providers agree or strongly agree with expanding recommendations for the new 20-valent pneumococcal conjugate vaccine (PCV20), according to research...
U.S. FDA Approves Prevnar 20, Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine for Infants and Children
NEW YORK--(BUSINESS WIRE) April 27, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Prevnar 20®(20-valent Pneumococcal Conjugate Vaccine) ...
FDA Approves Prevnar 20 (pneumococcal 20-valent conjugate vaccine) for Adults Ages 18 Years or Older
NEW YORK--(BUSINESS WIRE) June 08, 2021 – Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Prevnar 20™ (Pneumococcal 20-valent Conjugate Vaccine) f...